论文部分内容阅读
乳腺癌的治疗目前多采用多学科的综合治疗。除局部治疗外尚需应用全身性的辅助治疗,也就是在手术前后应用全身性的药物治疗,以杀灭局部区域淋巴结及远处脏器的亚临床微小转移灶,从而降低或推迟局部复发及减少远处转移,达到提高生存率,延长生存期的目的~([1])。由于化疗物具有很强的细胞毒性作用,加之化疗周期长,乳腺癌术后静脉血管的有限使用,易出现静脉炎,造成患者身心痛苦因而放弃化疗。选取我科收治的乳腺癌化疗致静脉炎患者50例,通过采取积极的、有
At present, the treatment of breast cancer with multi-disciplinary comprehensive treatment. In addition to local treatment is still required to apply systemic adjuvant therapy, that is, before and after the application of systemic drug therapy to kill local subclinical lymph nodes and distant organs metastasis, thereby reducing or delaying the local recurrence and Reduce the distant metastasis, to achieve the purpose of improving survival rate and prolonging survival period ([1]). As chemotherapy has a strong cytotoxic effect, combined with long cycle of chemotherapy, breast cancer postoperative venous vascular limited use, prone to phlebitis, resulting in patients with physical and mental pain and thus give up chemotherapy. 50 cases of phlebitis induced by chemotherapy in breast cancer were selected in our department. By adopting positive,